METASTASES
Clinical trials for METASTASES explained in plain language.
Never miss a new study
Get alerted when new METASTASES trials appear
Sign up with your email to follow new studies for METASTASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered t cells take on chest cancer in new trial
Disease control OngoingThis study tests a treatment using a patient's own immune cells (T cells) that are genetically modified to recognize and attack a protein called mesothelin found on cancer cells. The treatment is given through a tube in the chest to people with malignant pleural disease, includin…
Matched conditions: METASTASES
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Drug duo aims to tackle tough lung cancers after first treatment fails
Disease control OngoingThis trial tests whether combining sacituzumab tirumotecan (a targeted antibody-drug conjugate) with anlotinib (a multi-targeted pill) can shrink tumors or slow cancer growth in people with advanced non-squamous non-small cell lung cancer that has no known driver gene mutations. …
Matched conditions: METASTASES
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC